These are the main guidelines and studies our pages are based on.
Guidelines
- NICE. Osteoarthritis in over 16s: diagnosis and management (NG226), 2022. nice.org.uk
- American Academy of Orthopaedic Surgeons. Management of Osteoarthritis of the Knee (Non-Arthroplasty), 3rd ed., 2021. aaos.org
- Bannuru RR et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578-1589.
- Kolasinski SL et al. 2019 ACR/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res. 2020;72(2):149-162.
Studies
- Fransen M et al. Exercise for osteoarthritis of the knee. Cochrane Database Syst Rev. 2015.
- Messier SP et al. Weight loss reduces knee-joint loads in overweight and obese older adults with knee osteoarthritis. Arthritis Rheum. 2005;52(7):2026-2032.
- McAlindon TE et al. Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain. JAMA. 2017;317(19):1967-1975.
- Bennell KL et al. Effect of intra-articular platelet-rich plasma vs placebo injection on pain and medial tibial cartilage volume in knee osteoarthritis. JAMA. 2021;326(20):2021-2030.
- Freitag J et al. Adipose-derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis: a randomized controlled trial. Regen Med. 2019;14(3):213-230.
- Kise NJ et al. Exercise therapy versus arthroscopic partial meniscectomy for degenerative meniscal tear in middle aged patients. BMJ. 2016;354:i3740.
- Kirkley A et al. A randomized trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. 2008;359:1097-1107.
- US FDA. Important patient and consumer information about regenerative medicine therapies. fda.gov